Over 200 interstitial lung diseases, from ultra rare to relatively common, are recognised.
Most interstitial lung diseases are characterised by inflammation or fibrosis within the …

Introduction: Many forms of interstitial lung disease (ILD) can progress to extensive fibrosis
and respiratory failure. Idiopathic pulmonary fibrosis (IPF), which generally has a poor …

Idiopathic pulmonary fibrosis (IPF) is a chronic fibrotic lung disease of unknown etiology.
With a gradually increasing worldwide prevalence and a mortality rate exceeding that of …

Purpose Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal lung disease of
unknown origin whose incidence has been increasing over the latest decade partly as a …

The activity of the secreted phosphodiesterase autotaxin produces the inflammatory
signaling molecule LPA and has been associated with a number of human diseases …

Idiopathic pulmonary fibrosis (IPF), the most common form of idiopathic interstitial
pneumonia (IIP), is characterized by irreversible scarring of the lung parenchyma and …

Rationale: IL-13 is a potential therapeutic target for idiopathic pulmonary fibrosis (IPF);
preclinical data suggest a role in tissue fibrosis, and expression is increased in subjects with …

Background Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and irreversible
lung disease characterized by pulmonary fibrosis and lung dysfunction, ultimately leading to …

Accurate assessment of idiopathic pulmonary fibrosis (IPF) disease severity is integral to the
care provided to patients with IPF. However, to date, there are no generally accepted or …

Rationale: Idiopathic pulmonary fibrosis (IPF) is a progressive and inevitably fatal condition
for which there are a lack of effective biomarkers to guide therapeutic decision making …